Related Experiment Video
Updated: Mar 11, 2026
09:58
Investigating the Three-dimensional Flow Separation Induced by a Model Vocal Fold Polyp
Published on: February 3, 2014
8.9K
Does treatment of paradoxical vocal fold movement disorder decrease asthma medication use?
Scott Kramer1, Brad deSilva1, L Arick Forrest1
1James Care Voice and Swallowing Disorders Clinic, The Ohio State University, Wexner Medical Center, Columbus, Ohio, U.S.A.
The Laryngoscope
|November 19, 2016
Summary
Diagnosing and treating paradoxical vocal fold movement disorder (PVFMD) significantly reduced asthma medication use in patients. This improvement occurred with symptom relief and regardless of pulmonary function test results.
Area of Science:
- Pulmonology
- Otolaryngology
- Respiratory Medicine
Background:
- Paradoxical vocal fold movement disorder (PVFMD) is often misdiagnosed as asthma, leading to unnecessary medication use.
- High rates of asthma medication use are observed in patients with PVFMD prior to diagnosis.
Purpose of the Study:
- To evaluate the impact of PVFMD diagnosis and treatment on asthma medication usage.
- To assess symptom improvement and correlate outcomes with pulmonary function tests (PFTs).
Main Methods:
- A prospective observational study involving patients newly diagnosed with PVFMD.
- Medication use and symptom improvement were tracked via questionnaires at baseline, first follow-up, and 6 months.
- Pulmonary function tests (PFTs) were reviewed where available.
Main Results:
- 85% of patients were using asthma medication at presentation.
- Following diagnosis and treatment, 79% of patients decreased their asthma medication use (P < .001).
- 82% of patients reported symptom improvement, independent of PFT patterns.
Conclusions:
- Diagnosis and treatment of PVFMD effectively reduce the need for asthma medication.
- Symptom improvement in PVFMD patients is associated with decreased asthma medication use.
- Asthma medication is frequently overused in patients with undiagnosed PVFMD.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
404
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
404
01:19Mitral Valve Prolapse III: Nursing Management
500
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
500
01:25Mitral Regurgitation III: Medical Management
484
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
484
01:22Mitral Valve Prolapse II: Assessment and Management
935
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
935
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K